In addition, the absence of ER and PR expression in breast cancers in studies conducted to date indicates a poor prognosis in general, while c-erbB2 and Ki-67 (cell proliferation marker) positivity have been presented as markers showing the invasiveness and metastasis capacity of the tumor [22–24]. Here, ESR1 is linked to breast carcinoma.